[PDF][PDF] Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor–positive breast cancer
Journal of clinical oncology, 2006•researchgate.net
Purpose The 21-gene recurrence score (RS) assay quantifies the likelihood of distant
recurrence in women with estrogen receptor–positive, lymph node–negative breast cancer
treated with adjuvant tamoxifen. The relationship between the RS and chemotherapy benefit
is not known.
recurrence in women with estrogen receptor–positive, lymph node–negative breast cancer
treated with adjuvant tamoxifen. The relationship between the RS and chemotherapy benefit
is not known.
Purpose
The 21-gene recurrence score (RS) assay quantifies the likelihood of distant recurrence in women with estrogen receptor–positive, lymph node–negative breast cancer treated with adjuvant tamoxifen. The relationship between the RS and chemotherapy benefit is not known.
researchgate.net